Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Common Stock, $0.0001 Par Value
-
Shares outstanding
-
6,471,450
-
Number of holders
-
15
-
Total 13F shares, excl. options
-
113,859
-
Shares change
-
+113,737
-
Total reported value, excl. options
-
$142,327
-
Value change
-
+$142,173
-
Number of buys
-
13
-
Price
-
$1.25
Significant Holders of MUSTANG BIO, INC. - Common Stock, $0.0001 Par Value (MBIO) as of Q1 2025
15 filings reported holding MBIO - MUSTANG BIO, INC. - Common Stock, $0.0001 Par Value as of Q1 2025.
MUSTANG BIO, INC. - Common Stock, $0.0001 Par Value (MBIO) has 15 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 113,859 shares
of 6,471,450 outstanding shares and own 1.8% of the company stock.
Largest 10 shareholders include UBS Group AG (47,540 shares), Anson Funds Management LP (45,716 shares), GEODE CAPITAL MANAGEMENT, LLC (15,767 shares), Tower Research Capital LLC (TRC) (1,900 shares), BlackRock, Inc. (1,665 shares), SBI Securities Co., Ltd. (402 shares), WELLS FARGO & COMPANY/MN (400 shares), MORGAN STANLEY (298 shares), HARBOUR INVESTMENTS, INC. (76 shares), and JPMORGAN CHASE & CO (68 shares).
This table shows the top 15 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.